{"nctId":"NCT00833898","briefTitle":"Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)","startDateStruct":{"date":"2008-11"},"conditions":["Hematopoietic/Lymphoid Cancer"],"count":298,"armGroups":[{"label":"Caregiver Control","type":"NO_INTERVENTION","interventionNames":[]},{"label":"Caregiver Intervention","type":"EXPERIMENTAL","interventionNames":["Device: Paced respiration as part of PEPRR","Behavioral: PEPRR"]}],"interventions":[{"name":"Paced respiration as part of PEPRR","otherNames":["RESPeRATE™"]},{"name":"PEPRR","otherNames":["Psychoeducation & Paced Respiration/Relaxation"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* DISEASE CHARACTERISTICS (Meets all of the following criteria):\n\n  * Patient undergoing allogeneic bone marrow transplantation (BMt)\n  * Primary caregiver of a BMT patient\n  * Has provided care for the patient for at least 50 days of the required 100 days of caregiving following transplant (e.g., 50% of the total time)\n* PATIENT CHARACTERISTICS:\n\n  * Able to read and speak English\n  * Has telephone access\n  * No serious medical condition likely to influence immune and neuroendocrine parameters (caregiver)\n  * Alcohol consumption limited to \\< 2 drinks/day (caregiver)\n  * No history of a psychiatric illness unrelated to the experience as a caregiver within the past 18 months (caregiver)\n  * No history of a psychiatric illness unrelated to the BMT within the past 18 months (patient)\n\nExclusion Criteria:\n\n\\- PRIOR CONCURRENT THERAPY:\n\n• No concurrent steroid medications (caregiver)","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Behavioral - Stress Level as Measured by the Perceived Stress Scale (PSS)","description":"The Perceived Stress Scale (PSS) measures the overall level of stress. This instrument contains 14 items accessing overall appraisals of stress in the past month. Minimum score (best value)=0. Maximum score (worst value)=56. A higher score indicates greater stress.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23.5","spread":null},{"groupId":"OG001","value":"22.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"21.6","spread":null},{"groupId":"OG001","value":"22.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"23.0","spread":null},{"groupId":"OG001","value":"20.0","spread":null}]}]}]},{"type":"PRIMARY","title":"Physiological - Cortisol Awakening Response (CAR)","description":"Saliva will be collected using SPIT booklets containing four separate filter papers corresponding to collection times separated by waxed paper. Subjects will be asked to moisten a filter paper 1) immediately after waking, 2) 30 min later, 3) before lunch and 4) 10 hours after waking. They will be asked to collect these samples on three days typical for their schedules at each phase of the. They will indicate the time of each collection. Filters will dry in the booklet. Saliva samples will be aggregated across the three sampling days at each study phase to better reflect the typical pattern for each subject (see Smyth et al, 1997). The change from awakening to 30 minutes in cortisol (CAR) will be characterized by the change between waking and 30 min.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35","spread":null},{"groupId":"OG001","value":"0.25","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":null},{"groupId":"OG001","value":"0.36","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.33","spread":null},{"groupId":"OG001","value":"0.52","spread":null}]}]}]},{"type":"SECONDARY","title":"Depression Measured by the Center for Epidemiological Studies Depression Scale (CESD)","description":"The Center for Epidemiological Studies Depression Scale (CES-D) is a self-report 20-item scale designed to measure current depressive symptoms. Scores range from 0-60, with a score at or above 16 reflecting significant depressive symptomatology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15.9","spread":null},{"groupId":"OG001","value":"14.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.8","spread":null},{"groupId":"OG001","value":"13.6","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"16.3","spread":null},{"groupId":"OG001","value":"12.1","spread":null}]}]}]},{"type":"SECONDARY","title":"State Anxiety as Measured by the Spielberger State-Trait Anxiety Inventory (STAI)","description":"The State and Trait Anxiety Inventory (STAI) is a validated self-reporting instrument used to assess anxiety in adults. The inventory consists of 2 scales, state anxiety, which evaluates how the subject feels currently (transient anxiety), and trait anxiety, which evaluates how the subject feels generally (general tendency towards anxiety). Each scale consists of 20 questions, and a higher score indicates greater anxiety. Scores range from 20 (no anxiety) to 80 (maximum anxiety).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.4","spread":null},{"groupId":"OG001","value":"38.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"38.8","spread":null},{"groupId":"OG001","value":"38.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"41.6","spread":null},{"groupId":"OG001","value":"34.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Total Mood Disturbance (TMD) Score Using the Profile of Mood States (POMS)","description":"POMS stands for the Profile of Mood States. The POMS consists of 65 adjectives rated by subjects on a 5-point scale and six factors that derive from this scale are: 1) tension-anxiety, 2) depression-dejection, 3) anger-hostility, 4) fatigue-inertia, 5) vigor-activity and 6) Confusion-bewilderment. A Total Mood Disturbance (TMD) can be calculated by adding the scores for Tension, Depression, Anger, Fatigue and Confusion and then subtracting the score for Vigour. The range for the Total Mood Disturbance (TMD) score is 0 - 200, with higher score indicating more mood disturbance.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"66.8","spread":null},{"groupId":"OG001","value":"61.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"58.0","spread":null},{"groupId":"OG001","value":"59.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"65.2","spread":null},{"groupId":"OG001","value":"53.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Stress as Measured by Caregiver Burden Using the Caregiver Reaction Assessment (CRA)","description":"The Caregiver Reaction Assessment (CRA) is a measure of caregiver burden. This instrument contains 24 items reflecting the total caregiver situation in the past month. The scale refers to the caregiver. Minimum score (best value)=5. Maximum score (worst value)=25. Higher values reflect the experience of a higher burden.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.4","spread":null},{"groupId":"OG001","value":"10.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.8","spread":null},{"groupId":"OG001","value":"10.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"10.9","spread":null},{"groupId":"OG001","value":"10.6","spread":null}]}]}]},{"type":"SECONDARY","title":"Sleep as Assessed by the Pittsburgh Sleep Quality Inventory (PSQI) Total Score","description":"The Pittsburgh Sleep Quality Index (PSQI) is a self-rated scale to measure quality of sleep via questions regarding sleep latency, duration, efficiency, disturbances, use of sleep medication, and daytime dysfunction. Scores range from 0 to 21, where scores greater than 5 indicate poor sleep quality.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11.1","spread":null},{"groupId":"OG001","value":"11.4","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.2","spread":null},{"groupId":"OG001","value":"11.2","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"11.2","spread":null},{"groupId":"OG001","value":"11.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Mental Component Summary Via the Short-Form 36-Item Health Survey Version 2.0 (SF-36M)","description":"The Short-Form 36-Item Health Survey Version 2.0 (SF-36) is 36-item form related to 8 health concepts (physical functioning, role physical, role emotional, general health, social functioning, bodily pain, vitality, mental health) and 2 summary scores (physical and mental component summary). Role emotional, social functioning and mental health contribute to mental component; as well as the social functioning, vitality, and general health. Scores are based on a scale from 0 to 100, with higher scores defining more favorable health state.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"42.7","spread":null},{"groupId":"OG001","value":"45.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.8","spread":null},{"groupId":"OG001","value":"45.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"43.5","spread":null},{"groupId":"OG001","value":"47.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Physical Component Summary Via the Short-Form 36-Item Health Survey Version 2.0 (SF-36P)","description":"The Short-Form 36-Item Health Survey Version 2.0 (SF-36) is 36-item form related to 8 health concepts (physical functioning, role physical, role emotional, general health, social functioning, bodily pain, vitality, mental health) and 2 summary scores (physical and mental component summary). Physical functioning, role physical and bodily pain contribute to physical component; as well as the social functioning, vitality, and general health. Scores are based on a scale from 0 to 100, with higher scores defining more favorable health state.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53.8","spread":null},{"groupId":"OG001","value":"54.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"54.0","spread":null},{"groupId":"OG001","value":"52.9","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"53.7","spread":null},{"groupId":"OG001","value":"54.0","spread":null}]}]}]},{"type":"SECONDARY","title":"Stress as Measured by the Impact of Events Scale (IES)","description":"The Impact of Events Scale (IES), a widely accepted measure for evaluating intrusive thoughts regarding an event or situation. The scale consists of 15 items (7 measuring intrusive thoughts and 8 measuring avoidance) scored on a 5-point Likert Scale. Minimum score (best value)=0. Maximum score (worst value)=75. Scores over 20 indicate significant levels of PTS-like symptoms. The IES is anchored to the caregiving experience.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.4","spread":null},{"groupId":"OG001","value":"29.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"31.0","spread":null},{"groupId":"OG001","value":"29.1","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"30.3","spread":null},{"groupId":"OG001","value":"28.4","spread":null}]}]}]},{"type":"SECONDARY","title":"The Slope of the Diurnal Decline in Salivary Cortisol (SlopeC)","description":"The SlopeC has been noted to be affected by stressful experiences. From diurnal saliva collections at each phase we will fit curves between awake, before lunch, and 10 hours after awaking to characterize the diurnal change in salivary cortisol (SlopeC).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.12","spread":null},{"groupId":"OG001","value":"-0.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.10","spread":null},{"groupId":"OG001","value":"-0.12","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.12","spread":null},{"groupId":"OG001","value":"-0.11","spread":null}]}]}]},{"type":"SECONDARY","title":"The Slope of the Diurnal Decline (SlopeD) in Salivary Dehydroepiandrosterone (DHEA)","description":"The SlopeD has been noted to be affected by affective disorders such as depression. From diurnal saliva collections at each phase we will fit curves between awake, before lunch, and +10 hours after awaking to characterize the diurnal change in salivary DHEA.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.11","spread":null},{"groupId":"OG001","value":"-0.13","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":null},{"groupId":"OG001","value":"-0.15","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":null},{"groupId":"OG001","value":"-0.17","spread":null}]}]}]},{"type":"SECONDARY","title":"Area Under the Curve for Salivary Cortisol (AUCc)","description":"The AUCc will be determined between awaking, 30 minutes after awaking, prior to lunch, and 10 hours after awaking from saliva samples collected using a special filter collection device applied in this study. This area will be an estimate of total cortisol released during this time period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.85","spread":null},{"groupId":"OG001","value":"3.65","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.78","spread":null},{"groupId":"OG001","value":"3.80","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.77","spread":null},{"groupId":"OG001","value":"3.68","spread":null}]}]}]},{"type":"SECONDARY","title":"Area Under the Curve for Salivary DHEA (AUCd)","description":"The AUCd will be determined between awaking, 30 minutes after awaking, prior to lunch, and 10 hours after awaking from saliva samples collected using a special filter collection device applied in this study. This area will be an estimate of total DHEA released during this time period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.44","spread":null},{"groupId":"OG001","value":"1.64","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.52","spread":null},{"groupId":"OG001","value":"1.41","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":null},{"groupId":"OG001","value":"1.35","spread":null}]}]}]},{"type":"SECONDARY","title":"Host Defense Assessed by Natural Killer (NK) Cell Cytotoxicity","description":"The activity of natural killer (NK) cells is modified by psychosocial and behavioral states (Cacioppo et al., 1998; Irwin et al., 1991; Kiecolt-Glaser et al., 1991; Kiecolt-Glaser, 1999; Kiecolt-Glaser, McGuire, Robles, et al., 2002a; Kiecolt-Glaser, McGuire, Robles, et al., 2002b). Natural cytotoxicity will be determined toward K562 target cell lines as previously described (Laudenslager et al., 1998; Scanlan, et al., 1995). Percent lysis at each effector to target ratio will be found from the median value of each triplicate determination and from which the percent lysis/NK + cell will be determined for 20% lysis (lytic units/NK+ cell).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.01","spread":null},{"groupId":"OG001","value":"-1.07","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.09","spread":null},{"groupId":"OG001","value":"-1.17","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.09","spread":null},{"groupId":"OG001","value":"-1.27","spread":null}]}]}]},{"type":"SECONDARY","title":"Plasma C-reactive Protein (CRP)","description":"Plasma c-reactive (CRP) is an acute phase reactant that has been found to be predictive of cardiovascular disease. Is is also an inflammatory marker that will be assessed using high sensitivity CRP assays.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.18","spread":null},{"groupId":"OG001","value":"0.27","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.03","spread":null},{"groupId":"OG001","value":"-0.10","spread":null}]}]}]},{"type":"SECONDARY","title":"Plasma Inflammatory Marker Interleukin 1 Beta (IL-1 Beta)","description":"Inflammatory markers increase in association with stress. IL-1 beta is an inflammatory marker that will be determined in plasma using multiplex array technology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":".39","spread":".62"},{"groupId":"OG001","value":".39","spread":".73"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":".39","spread":".70"},{"groupId":"OG001","value":".39","spread":".22"}]}]}]},{"type":"SECONDARY","title":"Plasma Inflammatory Marker Interleukin 6 (IL-6)","description":"Inflammatory markers increase in association with stress. IL-6 is an inflammatory marker that will be assessed using high sensitivity IL-6 assays.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.33","spread":null},{"groupId":"OG001","value":"-0.56","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.13","spread":null},{"groupId":"OG001","value":"-0.45","spread":null}]}]}]},{"type":"SECONDARY","title":"Plasma Inflammatory Marker Interleukin 4 (IL-4)","description":"Inflammatory markers increase in association with stress. IL-4 is an anti inflammatory marker that will be determined in plasma using multiplex array technology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":"1.29"},{"groupId":"OG001","value":"1.56","spread":"0.00"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":"4.02"},{"groupId":"OG001","value":"1.56","spread":"0.00"}]}]}]},{"type":"SECONDARY","title":"Plasma Inflammatory Marker Interleukin 10 (IL-10)","description":"Inflammatory markers increase in association with stress. IL-10 is an anti inflammatory marker that will be determined in plasma using multiplex array technology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.72","spread":"3.50"},{"groupId":"OG001","value":"1.60","spread":"1.19"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.60","spread":"2.69"},{"groupId":"OG001","value":"1.60","spread":"1.33"}]}]}]},{"type":"SECONDARY","title":"Plasma Inflammatory Marker Tumor Necrosis Factor (TNF)","description":"Inflammatory markers increase in association with stress. TNF is an inflammatory marker that will be determined in plasma using multiplex array technology.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.70","spread":"5.29"},{"groupId":"OG001","value":"4.70","spread":"2.01"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.70","spread":"5.37"},{"groupId":"OG001","value":"4.70","spread":"2.69"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":74},"commonTop":[]}}}